{{Rsnum
|rsid=6123045
|Gene=NFATC2
|Chromosome=20
|position=51502303
|Orientation=plus
|GMAF=0.2736
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=NFATC2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 51.8 | 37.5 | 10.7
| HCB | 44.5 | 45.3 | 10.2
| JPT | 40.2 | 50.9 | 8.9
| YRI | 71.4 | 26.5 | 2.0
| ASW | 70.2 | 26.3 | 3.5
| CHB | 44.5 | 45.3 | 10.2
| CHD | 36.7 | 49.5 | 13.8
| GIH | 33.7 | 51.5 | 14.9
| LWK | 71.8 | 28.2 | 0.0
| MEX | 63.8 | 34.5 | 1.7
| MKK | 62.2 | 32.1 | 5.8
| TSI | 46.1 | 41.2 | 12.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=20628086
|Title=Variation at the NFATC2 Locus Increases the Risk of Thiazolinedinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}